MHRA-100054-PIP01-21

Key Facts

Active Substance
Active Substance:
  • RO7496998 (AT-527)
Invented Name
Not available at present
PIP Number MHRA-100054-PIP01-21
Pharmaceutical form(s)
Pharmaceutical form(s):
  • Tablet
Therapeutic area
  • Infectious diseases
  • Other: Pandemic
Conditions / Indications
Conditions / Indications:
  • Treatment of coronavirus disease 2019 (COVID-19)
Route(s) of administration
Route(s) of administration:
  • Oral use
PIP applicant
Decision Type
Decision Type
P: decision agreeing on a paediatric investigation plan, with or without partial waiver(s) or deferrals(s)
Compliance Check
Compliance Check
No
Compliance Check Decision Date
Compliance Check Procedure Number

Decision Document

Decision Document Decision Document on a Paediatric Investigation Plan (PIP):RO7496998 (AT-527).pdf
Published Date 18/03/2022